UBS Group AG Acquires 16,976 Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

UBS Group AG lifted its holdings in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRAFree Report) by 4.0% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 443,887 shares of the real estate investment trust’s stock after purchasing an additional 16,976 shares during the period. UBS Group AG owned 0.19% of Sabra Health Care REIT worth $6,334,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the business. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in shares of Sabra Health Care REIT by 0.6% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 136,667 shares of the real estate investment trust’s stock worth $1,931,000 after purchasing an additional 825 shares during the last quarter. Retirement Systems of Alabama boosted its holdings in Sabra Health Care REIT by 0.3% in the fourth quarter. Retirement Systems of Alabama now owns 289,592 shares of the real estate investment trust’s stock valued at $4,132,000 after acquiring an additional 890 shares during the last quarter. Van ECK Associates Corp boosted its holdings in Sabra Health Care REIT by 4.3% in the third quarter. Van ECK Associates Corp now owns 27,111 shares of the real estate investment trust’s stock valued at $378,000 after acquiring an additional 1,124 shares during the last quarter. M&T Bank Corp boosted its holdings in Sabra Health Care REIT by 6.3% in the fourth quarter. M&T Bank Corp now owns 25,546 shares of the real estate investment trust’s stock valued at $365,000 after acquiring an additional 1,517 shares during the last quarter. Finally, Natixis Advisors L.P. boosted its holdings in Sabra Health Care REIT by 8.2% in the fourth quarter. Natixis Advisors L.P. now owns 22,270 shares of the real estate investment trust’s stock valued at $317,000 after acquiring an additional 1,696 shares during the last quarter. Institutional investors own 99.40% of the company’s stock.

Insider Activity

In other Sabra Health Care REIT news, Director Catherine Cusack acquired 7,000 shares of the business’s stock in a transaction dated Wednesday, May 22nd. The shares were acquired at an average price of $14.43 per share, for a total transaction of $101,010.00. Following the acquisition, the director now directly owns 46,385 shares of the company’s stock, valued at approximately $669,335.55. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.10% of the stock is currently owned by company insiders.

Sabra Health Care REIT Trading Down 1.0 %

NASDAQ:SBRA opened at $14.27 on Friday. Sabra Health Care REIT, Inc. has a fifty-two week low of $11.36 and a fifty-two week high of $14.92. The company has a debt-to-equity ratio of 0.89, a current ratio of 4.33 and a quick ratio of 4.33. The stock has a market capitalization of $3.30 billion, a PE ratio of 71.35, a price-to-earnings-growth ratio of 2.34 and a beta of 1.22. The business’s 50-day simple moving average is $14.23 and its 200-day simple moving average is $14.10.

Sabra Health Care REIT Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, May 31st. Stockholders of record on Monday, May 20th were issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 8.41%. The ex-dividend date of this dividend was Friday, May 17th. Sabra Health Care REIT’s dividend payout ratio (DPR) is presently 600.00%.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. Wedbush reiterated an “outperform” rating and issued a $17.00 price target on shares of Sabra Health Care REIT in a report on Thursday, February 29th. Scotiabank raised their price target on Sabra Health Care REIT from $14.00 to $15.00 and gave the company a “sector perform” rating in a report on Wednesday, May 15th. Six equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, Sabra Health Care REIT has a consensus rating of “Moderate Buy” and an average target price of $15.71.

Check Out Our Latest Stock Report on SBRA

Sabra Health Care REIT Company Profile

(Free Report)

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.

Featured Articles

Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Health Care REIT, Inc. (NASDAQ:SBRAFree Report).

Institutional Ownership by Quarter for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.